Wang L, Sadoun E, Stephens R E, Ward P E
Department of Physiology, Ohio State University, Columbus 43210.
Peptides. 1994;15(3):497-503. doi: 10.1016/0196-9781(94)90212-7.
Analysis of SP and NKA metabolism by human vascular endothelium, relative to that in human plasma, identified integrative, multiple pathways for the processing of circulating SP (but not NKA) by angiotensin-converting enzyme (ACE; EC 3.4.15.1), dipeptidyl(amino)peptidase IV (DAP IV; EC 3.4.14.5), and aminopeptidase M (AmM; EC 3.4.11.2). In contrast, SP and NKA, which may diffuse into or be neurally released within the vessel wall, were both metabolized by smooth muscle neutral endopeptidase-24.11 (NEP-24.11; EC 3.4.24.11). Collectively, these studies indicate peptide-specific and site-specific differential processing of SP and NKA by human plasma and vasculature.
对人血管内皮细胞中P物质(SP)和神经激肽A(NKA)代谢情况相对于人血浆中的代谢情况进行分析,确定了血管紧张素转换酶(ACE;EC 3.4.15.1)、二肽基(氨基)肽酶IV(DAP IV;EC 3.4.14.5)和氨肽酶M(AmM;EC 3.4.11.2)处理循环中的SP(而非NKA)的综合、多种途径。相比之下,可能扩散进入血管壁或在血管壁内由神经释放的SP和NKA均由平滑肌中性内肽酶-24.11(NEP-24.11;EC 3.4.24.11)代谢。总体而言,这些研究表明人血浆和脉管系统对SP和NKA进行了肽特异性和位点特异性的差异处理。